HBV DNA and HBsAg: Early Prediction of Response to Peginterferon α-2a in HBeAg-Negative Chronic Hepatitis B

Objective: The proportion of hepatitis e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients in China has increased rapidly. However, the response of these patients to peginterferon (peg-IFN) treatment is poor, and the antiviral treatment strategies are inconsistent. This study aimed to inve...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Med Sci
Auteurs principaux: Zhang, Chong, Yang, Zhengrong, Wang, Ziyi, Dou, Xiaoguang, Sheng, Qiuju, Li, Yanwei, Han, Chao, Ding, Yang
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2020
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7053355/
https://ncbi.nlm.nih.gov/pubmed/32132873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.39775
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires